COLL vs GRMN · P/E 17, rev $181.9M vs P/E 28, rev $6.30B
Collegium Pharmaceutical Inc (COLL) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported GRMN revenue for 2024-12-28 was $6.30B. Net income was $1.41B. Revenue was up 20.4% from 2023-12-30 to 2024-12-28. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the COLL and GRMN stock pages for the full models.
Not investment advice.